Introduction Recent news of Merck’s decision to scrap its £1 billion research center in King’s Cross, London, has raised alarms about the future of pharmaceutical investments in the UK. Sir John Bell, a prominent figure in the medical field, has echoed concerns about the UK’s competitiveness in attracting major pharmaceutical companies. This article delves into…